Skip to content

Prevention of Acute Radiation Enteritis With Glutamine

Efficacy of Glutamine in the Prevention of Acute Radiation Enteritis Among Patients Treated With Radiation of Abdomen and Pelvis.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00828399
Enrollment
70
Registered
2009-01-23
Start date
2009-01-31
Completion date
2011-05-31
Last updated
2011-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Radiation Enteritis

Keywords

Radiotherapy, Diarrhoea, Glutamine, Oxydative stress, Calprotectin, Citrulline

Brief summary

Ionizing radiation has cytotoxic effects, and is commonly used as treatment for neoplasm. A common adverse effect of radiation is acute diarrhoea. Glutamine is an aminoacid with antioxidant effects that can protect tissues of damage dued to radiation. The investigators designed a randomized, double-blind trial phase III to study if glutamine prevents acute radiation enteritis.

Interventions

DIETARY_SUPPLEMENTGlutamine

Oral glutamine 30g/day

DIETARY_SUPPLEMENTWhole protein

Oral whole protein 30 g/day

Sponsors

Castilla-León Health Service
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 yr * Gynaecological,prostatic, rectal or other abdominal cancer * Radiotherapy with/without chemotherapy

Exclusion criteria

* life expectancy \< 1 yr * Age \< 18 yr * gut diseases: inflammatory bowel disease,sprue, irritable bowel disease... * moderate to severe chronic renal failure * hepatic cirrhosis

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with acute radiation enteritis2 monthsRTOG criteria

Secondary

MeasureTime frame
Reduction in inflammatory markers and oxydative stress2 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026